TY - JOUR
T1 - Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease
AU - Claus, Laura R
AU - Chen, Chuan
AU - Stallworth, Jennifer
AU - Turner, Joshua L
AU - Slaats, Gisela
AU - Hawks, Alexandra L
AU - Mabillard, Holly
AU - Senum, Sarah R
AU - Srikanth, Sujata
AU - Flanagan-Steet, Heather
AU - Louie, Raymond J
AU - Silver, Josh
AU - Lerner-Ellis, Jordan
AU - Morel, Chantal
AU - Mighton, Chloe
AU - Sleutels, Frank
AU - van Slegtenhorst, Marjon
AU - van Ham, Tjakko
AU - Brooks, Alice S
AU - Dorresteijn, Eiske M
AU - Barakat, Tahsin Stefan
AU - Dahan, Karin
AU - Demoulin, Nathalie
AU - Goffin, Eric Jean
AU - Olinger, Eric
AU - Larsen, Martin
AU - Hertz, Jens Michael
AU - Lilien, Marc R
AU - Obeidová, Lena
AU - Seeman, Tomas
AU - Stone, Hillarey K
AU - Kerecuk, Larissa
AU - Gurgu, Mihai
AU - Yousef Yengej, Fjodor A
AU - Ammerlaan, Carola Me
AU - Rookmaaker, Maarten B
AU - Hanna, Christian
AU - Rogers, R Curtis
AU - Duran, Karen
AU - Peters, Edith
AU - Sayer, John A
AU - van Haaften, Gijs
AU - Harris, Peter C
AU - Ling, Kun
AU - Mason, Jennifer M
AU - van Eerde, Albertien M
AU - Steet, Richard
N1 - Funding Information:
We thank the study participants and their families for their contribution. We are grateful to David Beier and Scott Houghtaling at Seattle Children's Research Institute for sharing their rabbit polyclonal NEK8 antibody. We thank Sebastiaan Knoppert from University Medical Center Utrecht, Darren Wallace, Kansas PKD Research and Translational Center (DK126126), and the PKD Foundation for their help in obtaining kidney tissue and imaging of nephrectomies from 2 families. We also thank Marijn Stokman for her valuable input. This work was supported by the Dutch Kidney Foundation (18OKG19 to AMvE), the Greenwood Genetic Center, a Clemson University R-initiative grant, National Institutes of Health (NIH) grant 5R35GM142512 to JMM, and NIH grants DK058816 and DK059597 to PCH. KL and CC were funded by a Department of Defense grant (W81XWH2010214). JL-E was funded by the McLaughlin Centre (grant nos. MC-2012-13, MC-2014-11-1, and MC-2017-12) and CIHR- Champions of Genetics: Building the Next Generation Grant (FRN: 135730). The study was supported by an Early PostdocMobility Stipendium and a PostdocMobility Stipendium, Swiss National Science Foundation (P2ZHP3_195181 and P500PB_206851), and Kidney Research UK (Paed_RP_001_20180925) (to EO); Kidney Research UK and the Northern Counties Kidney Research Fund (to JAS), and the Medical Research Council (to HM). Several authors of this publication are members of the European Reference Network for Rare Kidney Diseases (ERKNet) – Project ID No. 739532. AMvE is a member of the Health Holland IMAGEN consortium (LSHM20009). TSB is supported by the Netherlands Organisation for Scientific Research (ZonMW Veni, grant 91617021), an Erasmus MC Fellowship 2017, and Erasmus MC Human Disease Model Award 2018. Part of this research was made possible through access to the data and findings generated by the GeNepher biobank (TCBio 22-076) and the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
Funding Information:
We thank the study participants and their families for their contribution. We are grateful to David Beier and Scott Houghtaling at Seattle Children’s Research Institute for sharing their rabbit polyclonal NEK8 antibody. We thank Sebastiaan Knoppert from University Medical Center Utrecht, Darren Wallace, Kansas PKD Research and Translational Center (DK126126), and the PKD Foundation for their help in obtaining kidney tissue and imaging of nephrectomies from 2 families. We also thank Marijn Stokman for her valuable input. This work was supported by the Dutch Kidney Foundation (18OKG19 to AMvE), the Greenwood Genetic Center, a Clemson University R-initiative grant, National Institutes of Health (NIH) grant 5R35GM142512 to JMM, and NIH grants DK058816 and DK059597 to PCH. KL and CC were funded by a Department of Defense grant (W81XWH2010214). JL-E was funded by the McLaughlin Centre (grant nos. MC-2012-13, MC-2014-11-1, and MC-2017-12) and CIHR- Champions of Genetics: Building the Next Generation Grant (FRN: 135730). The study was supported by an Early PostdocMobility Stipendium and a PostdocMobility Stipendium, Swiss National Science Foundation (P2ZHP3_195181 and P500PB_206851), and Kidney Research UK (Paed_RP_001_20180925) (to EO); Kidney Research UK and the Northern Counties Kidney Research Fund (to JAS), and the Medical Research Council (to HM). Several authors of this publication are members of the European Reference Network for Rare Kidney Diseases (ERKNet) – Project ID No. 739532. AMvE is a member of the Health Holland IMAGEN consortium (LSHM20009). TSB is supported by the Netherlands Organisation for Scientific Research (ZonMW Veni, grant 91617021), an Erasmus MC Fellowship 2017, and Erasmus MC Human Disease Model Award 2018. Part of this research was made possible through access to the data and findings generated by the GeNepher biobank (TCBio 22-076) and the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
Publisher Copyright:
© 2023 International Society of Nephrology
PY - 2023/11
Y1 - 2023/11
N2 - Autosomal dominant polycystic kidney disease (ADPKD) resulting from pathogenic variants in PKD1 and PKD2 is the most common form of PKD, but other genetic causes tied to primary cilia function have been identified. Biallelic pathogenic variants in the serine/threonine kinase NEK8 cause a syndromic ciliopathy with extra-kidney manifestations. Here we identify NEK8 as a disease gene for ADPKD in 12 families. Clinical evaluation was combined with functional studies using fibroblasts and tubuloids from affected individuals. Nek8 knockout mouse kidney epithelial (IMCD3) cells transfected with wild type or variant NEK8 were further used to study ciliogenesis, ciliary trafficking, kinase function, and DNA damage responses. Twenty-one affected monoallelic individuals uniformly exhibited cystic kidney disease (mostly neonatal) without consistent extra-kidney manifestations. Recurrent de novo mutations of the NEK8 missense variant p.Arg45Trp, including mosaicism, were seen in ten families. Missense variants elsewhere within the kinase domain (p.Ile150Met and p.Lys157Gln) were also identified. Functional studies demonstrated normal localization of the NEK8 protein to the proximal cilium and no consistent cilia formation defects in patient-derived cells. NEK8-wild type protein and all variant forms of the protein expressed in Nek8 knockout IMCD3 cells were localized to cilia and supported ciliogenesis. However, Nek8 knockout IMCD3 cells expressing NEK8-p.Arg45Trp and NEK8-p.Lys157Gln showed significantly decreased polycystin-2 but normal ANKS6 localization in cilia. Moreover, p.Arg45Trp NEK8 exhibited reduced kinase activity in vitro. In patient derived tubuloids and IMCD3 cells expressing NEK8-p.Arg45Trp, DNA damage signaling was increased compared to healthy passage-matched controls. Thus, we propose a dominant-negative effect for specific heterozygous missense variants in the NEK8 kinase domain as a new cause of PKD.
AB - Autosomal dominant polycystic kidney disease (ADPKD) resulting from pathogenic variants in PKD1 and PKD2 is the most common form of PKD, but other genetic causes tied to primary cilia function have been identified. Biallelic pathogenic variants in the serine/threonine kinase NEK8 cause a syndromic ciliopathy with extra-kidney manifestations. Here we identify NEK8 as a disease gene for ADPKD in 12 families. Clinical evaluation was combined with functional studies using fibroblasts and tubuloids from affected individuals. Nek8 knockout mouse kidney epithelial (IMCD3) cells transfected with wild type or variant NEK8 were further used to study ciliogenesis, ciliary trafficking, kinase function, and DNA damage responses. Twenty-one affected monoallelic individuals uniformly exhibited cystic kidney disease (mostly neonatal) without consistent extra-kidney manifestations. Recurrent de novo mutations of the NEK8 missense variant p.Arg45Trp, including mosaicism, were seen in ten families. Missense variants elsewhere within the kinase domain (p.Ile150Met and p.Lys157Gln) were also identified. Functional studies demonstrated normal localization of the NEK8 protein to the proximal cilium and no consistent cilia formation defects in patient-derived cells. NEK8-wild type protein and all variant forms of the protein expressed in Nek8 knockout IMCD3 cells were localized to cilia and supported ciliogenesis. However, Nek8 knockout IMCD3 cells expressing NEK8-p.Arg45Trp and NEK8-p.Lys157Gln showed significantly decreased polycystin-2 but normal ANKS6 localization in cilia. Moreover, p.Arg45Trp NEK8 exhibited reduced kinase activity in vitro. In patient derived tubuloids and IMCD3 cells expressing NEK8-p.Arg45Trp, DNA damage signaling was increased compared to healthy passage-matched controls. Thus, we propose a dominant-negative effect for specific heterozygous missense variants in the NEK8 kinase domain as a new cause of PKD.
KW - ciliopathy
KW - kinase
KW - NEK8
KW - polycystic kidney disease
UR - http://www.scopus.com/inward/record.url?scp=85171536885&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2023.07.021
DO - 10.1016/j.kint.2023.07.021
M3 - Article
C2 - 37598857
SN - 0085-2538
VL - 104
SP - 995
EP - 1007
JO - Kidney International
JF - Kidney International
IS - 5
ER -